Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Pfizer (NY: PFE )

28.52 +0.06 (+0.21%)
Official Closing Price Updated: 7:00 PM EDT, Oct 30, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 47,104,097
Open 28.31
Bid (Size) 28.48 (3)
Ask (Size) 28.53 (20)
Prev. Close 28.46
Today's Range 28.19 - 28.60
52wk Range 25.20 - 31.54
Shares Outstanding 5,606,688,356
Dividend Yield 5.75%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Amgen 'Laser-Focused' On Its Weight-Loss Shot As New Rival Pfizer Follows, Says CFO
The company expects to have topline results from a Phase 2 study later this year. 
Via Investor's Business Daily
GSK Stock Crumbles As Vaccine Sales Plummet And Miss Expectations
The company said revenue from RSV vaccine tumbled 72%. 
Via Investor's Business Daily

Performance

YTD
-4.07%
-4.07%
1 Month
-1.45%
-1.45%
3 Month
-6.61%
-6.61%
6 Month
+4.93%
+4.93%
1 Year
-6.68%
-6.68%

More News

Read More
Nasdaq Hits Record High Ahead Of Big Tech Earnings: Fear Index Remains In 'Greed' Zone
Via Benzinga
Why Pfizer Stock Tumbled on Tuesday
Via The Motley Fool
Pfizer (PFE) Q3 2024 Earnings Call Transcript
Via The Motley Fool
Topics Earnings
Exposures Financial
Biotech Momentum Trades For The Q4 Rally
Via Talk Markets
Pfizer Earnings Top Q3 Views; Pharma Giant Guides Higher
Via Investor's Business Daily
Tech Stocks Rise Ahead Of Key Earnings, Gold Smashes Records, Bitcoin Nears All-Time Highs: What's Driving Markets Tuesday?
Via Benzinga
Nasdaq Surges Over 100 Points; Pfizer Earnings Top Views
Via Benzinga
Pfizer Inc.’s Strong Q3 Performance: Beats Expectations With $1.06 EPS
Via Talk Markets
Pfizer Q3 Earnings: Revenue And Profit Beat On Heightened Demand For Paxlovid, Expects $10 Billion In 2024 Revenue From COVID Products
Via Benzinga
Exposures COVID-19
US Stocks Likely To Open Weaker As Investors Eye Alphabet, AMD And Pfizer Earnings: Expert Says Won't Be 'Surprised' If Earnings Exceed Wall Street Expectations
Via Benzinga
Pfizer Reports Strong Third-Quarter 2024 Results And Raises 2024 Guidance
From Pfizer Inc.
Via Business Wire
Dow Surges Over 250 Points Ahead Of Alphabet, Pfizer Earnings: Investor Sentiment Improves, Fear Index Remains In 'Greed' Zone
Via Benzinga
Topics Stocks
Exposures US Equities
Pfizer, Alphabet And 3 Stocks To Watch Heading Into Tuesday
Via Benzinga
Global Psychedelic Drugs Market Expected To Reach $10.2B By 2028 Amid Growing Mental Health Crises
Via Benzinga
What Lies In Store For Healthcare ETFs In Q3 Earnings?
Via Talk Markets
Topics ETFs
These 7 Blunt Words Just Opened a Can of Worms For Pfizer's Stock
Via The Motley Fool
3 Magnificent S&P 500 Dividend Stocks Down 43%, 20%, and 53% to Buy and Hold Forever
Via The Motley Fool
Topics Stocks
Exposures US Equities
3 Spooky Signs That You're About to Lose Your Money on a Healthcare Stock Investment
Via The Motley Fool
Pfizer, Live Nation Entertainment And More On CNBC's 'Final Trades'
Via Benzinga
Got $1,000? 2 Healthcare Stocks to Buy and Hold Forever.
Via The Motley Fool
3 Sweet Dividend Stocks to Treat Your Portfolio With This Halloween
Via The Motley Fool
Just After Pfizer's RSV Vaccine Approval For Younger Adults, GSK Layouts Encouraging Preliminary Data Showing Potential For Use In Larger Population
Via Benzinga
CDC And Prevention Advisory Panel Backs Expanded Use Of Pfizer And Merck's Pneumococcal Vaccines
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.